Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07684274
Early Screening for Multiple Myeloma Based on Liquid Biopsy cfDNA Fragmentomics
Sponsor: The First Affiliated Hospital with Nanjing Medical University
View on ClinicalTrials.gov
Summary
Study on Early Screening of Myeloma Based on Liquid Biopsy cfDNA Fragmentomics Technology. This study aims to construct and validate a set of machine learning models for the early screening of myeloma tailored to the Chinese population, based on plasma cfDNA fragmentomics features, to effectively distinguish myeloma patients from healthy individuals.
Key Details
Gender
All
Age Range
40 Years - Any
Study Type
OBSERVATIONAL
Enrollment
290
Start Date
2026-06-13
Completion Date
2027-12-31
Last Updated
2026-07-06
Healthy Volunteers
Yes